A secretin releasing peptide exists in dog pancreatic juice.
Canine pancreatic juice has been shown to stimulate exocrine pancreatic secretion in the dog. In the present study we investigated whether there is a secretin-releasing peptide in canine pancreatic juice. Pancreatic juice was collected from the dogs with Thomas gastric and duodenal cannulas while pancreatic secretion was stimulated by intravenous administration of secretin at 0.5 microg/kg/h and CCK-8 at 0.2 microg/kg/h, respectively. The pancreatic juice was separated into three different molecular weight (MW) fractions (Fr) by ultrafiltration (Fr 1; MW > 10,000, Fr 2; MW=10,000-4,000 and Fr 3; MW < 4,000), respectively. All the fractions were bioassayed in anesthetized rats. Fraction 3 dose-dependently and significantly stimulated pancreatic juice flow volume from 78.0% to 99.4% (p<0.05) and bicarbonate output from 128.9% to 202.1% (p<0.01), respectively. Plasma secretin concentration also increased from 1.2 +/- 0.5 pM to 5.0 +/- 0.8 pM and 6.0 +/- 1.0 pM (p<0.05). None of these fractions increased pancreatic protein secretion or plasma CCK level. The stimulatory effect of Fraction 3 on pancreatic secretion and the release of secretin was completely abolished by treatment with trypsin (1 mg/ml for 60 min at 37 degrees C) but not by heating (100 degrees C, 10 min). Intravenous injection of a rabbit anti-secretin serum, which rendered plasma secretin almost undetectable in rat plasma, also abolished Fr 3-stimulated pancreatic secretion of fluid and bicarbonate secretion. These observations suggest that a secretin-releasing peptide exists in the canine pancreatic juice. It is trypsin-sensitive and heat-resistant. This peptide may play a significant physiological role on the release of secretin and regulation of exocrine pancreatic secretion.
Li
P
P
The William and Sheila Konar Center for Digestive and Liver Diseases, University of Rochester Medical Center, NY 14642, USA.
Song
Y
Y
Lee
K Y
KY
Chang
T M
TM
Chey
W Y
WY
D000818:Animals; D001639:Bicarbonates / Q000378:metabolism; D002021:Buffers; D002766:Cholecystokinin / Q000378:metabolism; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005260:Female; D008297:Male; D008970:Molecular Weight; D010179:Pancreas / Q000187:drug effects / Q000378:metabolism; D010189:Pancreatic Juice / Q000737:chemistry*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012633:Secretin / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology*; D014357:Trypsin / Q000737:chemistry; D014462:Ultrafiltration
D001639:Bicarbonates; D002021:Buffers; C406426:secretin releasing peptide; D012633:Secretin; D002766:Cholecystokinin; D014357:Trypsin